Brief: Catalyst Biosciences Completes First Steps In Reverse Merger Plan
27/12/2022 16:34
Dec 27 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* CATALYST BIOSCIENCES COMPLETES FIRST STEPS IN REVERSE
MERGER
PLAN
Source text for Eikon: ID:nGNX4hYPzx
Further company coverage: CBIO.O
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes